These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6110218)

  • 1. EEG and behavioral profile of flutroline (CP-36,584), a novel antipsychotic drug.
    Fink M; Irwin P
    Psychopharmacology (Berl); 1980; 72(1):67-71. PubMed ID: 6110218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prolactin response to flutroline hydrochloride in schizophrenic patients.
    Kurland AA; Nagaraju A; Hanlon TE; Williams TG
    J Clin Pharmacol; 1983; 23(11-12):505-16. PubMed ID: 6141186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flutroline in the treatment of the schizophrenic patient.
    Kurland AA; Nagaraju A; Hanlon TE
    J Clin Pharmacol; 1982 Oct; 22(10):441-9. PubMed ID: 6129266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of three dosages of flutroline (CP-36,584) in the treatment of schizophrenia.
    McEvoy JP; Berney S; Wilson WH; Ban TA; Guy W
    Int Pharmacopsychiatry; 1980; 15(5):318-24. PubMed ID: 7021452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmaco-EEG study on antipsychotic drugs in healthy volunteers.
    Yoshimura M; Koenig T; Irisawa S; Isotani T; Yamada K; Kikuchi M; Okugawa G; Yagyu T; Kinoshita T; Strik W; Dierks T
    Psychopharmacology (Berl); 2007 May; 191(4):995-1004. PubMed ID: 17333135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic activity in 5-aryltetrahydro-gamma-carbolines.
    Harbert CA; Plattner JJ; Welch WM; Weissman A; Koe BK
    J Med Chem; 1980 Jun; 23(6):635-43. PubMed ID: 6104732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indoles. 10. Synthesis, structure and D2-affinity of beta-carboline analogs of flutroline].
    Lehmann J; Knoch F; Jiang N
    Arch Pharm (Weinheim); 1993 Dec; 326(12):947-51. PubMed ID: 7907210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic activity of substituted gamma-carbolines.
    Abou-Gharbia M; Patel UR; Webb MB; Moyer JA; Andree TH; Muth EA
    J Med Chem; 1987 Oct; 30(10):1818-23. PubMed ID: 2888898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gas chromatographic/mass spectrometric assay for flutroline, a gamma-carboline antipsychotic agent, with direct derivatization on a moving needle injector.
    Falkner FC; Fouda HG; Mullins FG
    Biomed Mass Spectrom; 1984 Sep; 11(9):482-5. PubMed ID: 6150732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies: Part II.
    Saletu B; Grünberger J; Linzmayer L; Dubini A
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):544-51. PubMed ID: 6140228
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic activity of the 5-aryltetrahydro-gamma-carboline series. Conformational requirements for interaction with central dopamine receptors.
    Harbert CA; Plattner JJ; Welch WM; Weissman A; Koe BK
    Mol Pharmacol; 1980 Jan; 17(1):38-42. PubMed ID: 6104285
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrinsic and antagonistic effects of beta-carboline FG 7142 on behavioral and EEG actions of benzodiazepines and pentobarbital in cats.
    Ongini E; Barzaghi C; Marzanatti M
    Eur J Pharmacol; 1983 Nov; 95(1-2):125-9. PubMed ID: 6421604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine.
    Herrmann WM; Schärer E; Delini-Stula A
    Pharmacopsychiatry; 1991 Nov; 24(6):196-205. PubMed ID: 1687485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of carbidine on the dopamine and serotonin receptors of the central nervous system].
    Zharkovskiĭ AM; Klassen NE; Zharkovskiĭ TA
    Biull Eksp Biol Med; 1985 Jun; 99(6):700-2. PubMed ID: 2861866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin releasing potencies of antipsychotic and related nonantipsychotic compounds in female rats: relation to clinical potencies.
    Hays SE; Poland RE; Rubin RT
    J Pharmacol Exp Ther; 1980 Aug; 214(2):362-7. PubMed ID: 6104725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies--Part I.
    Saletu B; Grünberger J; Linzmayer L; Dubini A
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):489-95. PubMed ID: 6139346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal effects of JL 13, a pyridobenzoxazepine derivative with an antipsychotic potential, on circulating prolactin levels in male rats.
    Liégeois JF; Bruhwyler J; Hendrick JC; Delarge J; Legros JJ; Damas J
    Neurosci Lett; 2002 Feb; 319(1):49-52. PubMed ID: 11814651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosing the antipsychotic medication olanzapine.
    Nemeroff CB
    J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
    Davila R; Gonzalez MA; Zumarraga M; Andia I; Guimon J; Silva RR; Friedhoff AJ
    Biol Psychiatry; 1995 Aug; 38(4):267-9. PubMed ID: 8547450
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychotropic agents: synthesis and antipsychotic activity of substituted beta-carbolines.
    Abou-Gharbia M; Patel UR; Moyer JA; Muth EA
    J Med Chem; 1987 Jun; 30(6):1100-5. PubMed ID: 2884314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.